Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

BD BV480 Mouse Anti-Human CD14

CD14 has been identified as a high affinity cell-surface receptor for complexes of lipopolysaccharide (LPS) and serum LPS-binding protein, LPB. BD Horizon™ BV480 Mouse Anti-Human CD14-specific antibody reacts with interfollicular macrophages, reticular dendritic cells and some Langerhans cells.

$208.00 - $420.00

Specifications

Product Type BV480 Mouse Anti-Human CD14
For Use With (Application) Flow Cytometry
Cross Reactivity QC Testing: Human
Form BV480
Sample Volume 5 μL
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
BDB566190
View Documents
BD
566190
25 Tests
Each for $208.00
Add to Cart
 
BDB566141
View Documents
BD
566141
100 Tests
Each for $420.00
Add to Cart
 
Description

Description

  • With an Ex Max of 436nm and Em Max at 478nm, BD Horizon™ BV480 can be excited by the violet laser and detected in the BD Horizon™ BV510 (525/40nm) filter set
  • BV480 has less spillover into the BV605 detector and, in general, is brighter than BV510
Specifications

Specifications

BV480 Mouse Anti-Human CD14
QC Testing: Human
5 μL
Aqueous buffered solution containing BSA and ≤0.09% sodium azide
Flow Cytometry
BV480
Store undiluted at 4°C
SDS
Documents

Documents

Product Certifications
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit